Development of Bag-1L as a therapeutic target in androgen receptor-dependent prostate cancer

Peer review process

This article was accepted for publication via eLife's original publishing model. eLife publishes the authors' accepted manuscript as a PDF only version before the full Version of Record is ready for publication. Peer reviews are published along with the Version of Record.

History

  1. Version of Record published
  2. Accepted Manuscript published
  3. Accepted
  4. Received

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Laura Cato
  2. Antje Neeb
  3. Adam Sharp
  4. Victor Buzón
  5. Scott B Ficarro
  6. Linxiao Yang
  7. Claudia Muhle-Goll
  8. Nane C Kuznik
  9. Ruth Riisnaes
  10. Daniel Nava Rodrigues
  11. Olivier Armant
  12. Victor Gourain
  13. Guillaume Adelmant
  14. Emmanuel A Ntim
  15. Thomas Westerling
  16. David Dolling
  17. Pasquale Rescigno
  18. Ines Figueiredo
  19. Friedrich Fauser
  20. Jennifer Wu
  21. Jaice T Rottenberg
  22. Liubov Shatkina
  23. Claudia Ester
  24. Burkhard Luy
  25. Holger Puchta
  26. Jakob Troppmair
  27. Nicole Jung
  28. Stefan Bräse
  29. Uwe Strähle
  30. Jarrod A Marto
  31. Gerd Ulrich Nienhaus
  32. Bissan Al-Lazikani
  33. Xavier Salvatella
  34. Johann S de Bono
  35. Andrew CB Cato
  36. Myles Brown
(2017)
Development of Bag-1L as a therapeutic target in androgen receptor-dependent prostate cancer
eLife 6:e27159.
https://doi.org/10.7554/eLife.27159

Share this article

https://doi.org/10.7554/eLife.27159